Chinook Therapeutics Inc Cvr (ADRO)
R&D to Revenue
243.78%
Quarterly · Period ending:
ADRO R&D to Revenue
Latest reported243.78%period ending
Latest reported243.78%period ending
ADRO Quarterly R&D/Revenue (18916.00% → 243.78%)
Latest values, visible window
High-resolution chart · PNG
ADRO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 243.7814% | |
| 199.2824% | |
| 113.4624% | |
| 416.4327% | |
| 323.1923% | |
| 345.2537% | |
| 495.937% | |
| 638.6149% | |
| 609.6964% | |
| 735.8848% | |
| 303.7272% | |
| 610.1704% | |
| 644.544% | |
| 362.3458% | |
| 545.3871% | |
| 537.9835% | |
| 502.0032% | |
| 68.9653% | |
| 519.2804% | |
| 65.9094% | |
| 61.6996% | |
| 136.9321% | |
| 111.197% | |
| 0% | |
| 235.6396% | |
| 548.5279% | |
| 18,916% |